Cancidas caspofungin regulatory update

The FDA's Antiviral Advisory Committee unanimously recommended approval of MRK's Cancidas, an inhibitor of beta 1,3-D-glucan in fungal cell walls, to treat invasive aspergillosis in patients who do no...